CVRx, Inc.

CVRX· Nasdaq· Surgical & Medical Instruments & Apparatus

Market cap
–
P/FCF
–
EV/Sales
–
FCF margin
-71.9%
ROIC, 5 yr avg
–
Revenue, 5 yr CAGR
+56.4%
We record prices for the companies we cover; CVRX is not one of them yet.

Company statistics

From the 10-Ks, computed in code · point at a figure for its formula

Profile · FY2025

Market cap
–
Enterprise value
–
Diluted shares
26.1M
Revenue
$56.7M
Free cash flow
-$40.8M
Owner earnings
-$51.8M

Valuation · FY2025

P/E
–
P/FCF
–
P/Owner earnings
–
EV/Sales
–
EV/FCF
–
P/B
–

Margins · FY2025

Gross
85.3%
Operating
-90.5%
Net
-94.1%
Free cash flow
-71.9%
Owner earnings
-91.4%
Stock pay
19.5%

Returns

ROIC, FY2025
–
ROIC, 5 yr avg
–
ROE, FY2025
-135.6%
ROE, 5 yr avg
-68.3%

Growth (CAGR)

Revenue, 3 yr
36.1%
Revenue, 5 yr
56.4%
Diluted EPS, 3 yr
–
Diluted EPS, 5 yr
–
Free cash flow, 3 yr
–
Free cash flow, 5 yr
–

Financial health · FY2025

Cash and investments
$75.7M
Total debt
$49.5M
Net cash
$26.2M
Debt/Equity
1.3x
Debt/FCF
–

Shareholder returns · FY2025

Dividend yield
–
Payout ratio
–
Buyback yield
–
Shareholder yield
–
Share count, 5 yr
–

Financials: ten years from the 10-Ks

Reported numbers open their filing · computed ones show the formula · ˢ split-adjusted

Revenue

$56.7M

+56.4% a year over 5 years

FY2020: Revenue $6.1MFY2021: Revenue $13.0MFY2022: Revenue $22.5MFY2023: Revenue $39.3MFY2024: Revenue $51.3MFY2025: Revenue $56.7M
FY2020FY2025

Margins

Gross85.3%Operating-90.5%Net-94.1%

FY2025

FY2020: Gross 76.2%, Operating -190.2%, Net -233.1%FY2021: Gross 72.1%, Operating -199.2%, Net -330.5%FY2022: Gross 77.8%, Operating -189.3%, Net -184.4%FY2023: Gross 84.1%, Operating -109.7%, Net -104.8%FY2024: Gross 83.8%, Operating -116.0%, Net -116.9%FY2025: Gross 85.3%, Operating -90.5%, Net -94.1%
FY2020FY2025

Free cash flow and owner earnings

Free cash flow-$40.8MOwner earnings-$51.8M

FY2025

FY2020: Free cash flow -$16.4M, Owner earnings -$16.5MFY2021: Free cash flow -$28.9M, Owner earnings -$30.8MFY2022: Free cash flow -$43.4M, Owner earnings -$47.2MFY2023: Free cash flow -$39.6M, Owner earnings -$45.9MFY2024: Free cash flow -$40.5M, Owner earnings -$59.6MFY2025: Free cash flow -$40.8M, Owner earnings -$51.8M
FY2020FY2025

Diluted shares

26.1M

+151.8% over 5 years, net dilution

FY2020: Diluted shares –FY2021: Diluted shares 10.4MFY2022: Diluted shares 20.5MFY2023: Diluted shares 20.8MFY2024: Diluted shares 22.6MFY2025: Diluted shares 26.1M
FY2020FY2025

Net cash

$26.2M

$26.2M more cash than debt

FY2020: Net cash $39.8MFY2021: Net cash $142.1MFY2022: Net cash $99.4MFY2023: Net cash $61.3MFY2024: Net cash $56.7MFY2025: Net cash $26.2M
FY2020FY2025

Every figure, year by year

Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
The business
Revenue$6.1M$13.0M$22.5M$39.3M$51.3M$56.7M
Revenue growth–115.4%72.4%74.9%30.5%10.4%
Gross margin76.2%72.1%77.8%84.1%83.8%85.3%
Operating margin-190.2%-199.2%-189.3%-109.7%-116.0%-90.5%
Net income-$14.1M-$43.1M-$41.4M-$41.2M-$60.0M-$53.3M
Net margin-233.1%-330.5%-184.4%-104.8%-116.9%-94.1%
Diluted EPS–$-4.16$-2.02$-1.99$-2.65$-2.04
Return on invested capital?––––––
Cash
Operating cash flow-$16.1M-$27.7M-$42.7M-$39.0M-$39.1M-$40.2M
Capital expenditure$311.0K$1.2M$685.0K$591.0K$1.4M$580.0K
Free cash flow-$16.4M-$28.9M-$43.4M-$39.6M-$40.5M-$40.8M
Stock-based compensation$132.0K$1.9M$3.9M$6.3M$19.1M$11.1M
Owner earnings?-$16.5M-$30.8M-$47.2M-$45.9M-$59.6M-$51.8M
Free cash flow per share–$-2.79$-2.11$-1.91$-1.79$-1.56
Capital allocation
Dividends paid––––––
Share repurchases––––––
Diluted shares–10.4M20.5M20.8M22.6M26.1M
Share count change?––98.2%1.1%8.9%15.4%
Balance sheet
Cash and equivalents$59.1M$142.1M$106.2M$90.6M$105.9M$75.7M
Short-term investments––––––
Total debt$19.3M$0$6.7M$29.2M$49.3M$49.5M
Net debt-$39.8M-$142.1M-$99.4M-$61.3M-$56.7M-$26.2M
Shareholders' equity-$293.2M$146.0M$109.2M$75.9M$71.1M$39.3M

Latest filings

All on EDGAR
2026-08-0610-QQuarterly report
2026-08-068-KEarnings release
2026-05-1210-QQuarterly report
2026-05-118-KEarnings release
2026-04-20DEF 14AProxy statement
2026-04-138-KEarnings release
2026-02-1310-KAnnual report
2026-02-128-KEarnings release
2026-01-128-KEarnings release
2025-11-0610-QQuarterly report

More from our coverage

All coverage